MARATTO

other · Zenodo (CERN European Organization for Nuclear Research)

Code for Integrated In Vivo and In Silico Analysis Reveals Aframomum Melegueta Neuroprotection Against LPS-Induced Memory Impairment Through TLR4/MD-2 Modulation

Abstract

Manuscript Submission Release (v1.0.0) This repository contains the source code and computational model supporting the findings of our study: "Integrated In Vivo and In Silico Analysis Reveals Aframomum Melegueta Neuroprotection Against LPS-Induced Memory Impairment Through TLR4/MD-2 Modulation" Contents: Molecular Dynamics Simulation Jupyter Notebook: Notebook containing full codes for simulation, processed trajectories for RMSD, RMSF, Binding Energy, and PCA analysis. Systems Neuropharmacology Model: Python implementation (Jupyter Notebook) of the differential equation framework modeling the NF-κB/Cytokine axis and Synaptic Rebound. Reproducibility: Self-contained environments to reproduce the Figures in the Results section. Usage: Please refer to README.md for instructions and the option to view code via Google Colab. Citation: If you use this code, please cite both the code DOI and the associated publication: Code: Oladele, T. S., Iteire, K. A., Ogunmiluyi, O. E., Adebisi, K. A., Siyanbade, A. J., Sulaiman, K. A., Leko, B. J., & Ijomone, O. M. (2026). Code for Integrated In Vivo and In Silico Analysis Reveals Aframomum Melegueta Neuroprotection Against LPS-Induced Memory Impairment Through TLR4/MD-2 Modulation (v1.0.0). Zenodo. https://doi.org/10.5281/zenodo.18487283

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5281/zenodo.18487283

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.